Recent Quarter Total Invested
$1.69 B
Recent Quarter Institutional Ownership Percentage
121.01%
Total Invested of Last Quarter
$1.85 B
Ownership Percentage of Last Quarter
123.2%
Akero Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 08/14/2024 | 6.88 M | $161.28 M | 12.32% | 11.59% |
| BLACKROCK INC. | 08/13/2024 | 5.59 M | $131.06 M | 14.19% | 9.42% |
| RTW INVESTMENTS, LP | 08/14/2024 | 5.43 M | $127.43 M | 0.00% | 9.16% |
| GENERAL ATLANTIC, L.P. | 08/14/2024 | 5.23 M | $122.79 M | 0.00% | 8.83% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 5.11 M | $119.99 M | -1.89% | 8.62% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 4.15 M | $97.28 M | 2.11% | 6.99% |
| VANGUARD GROUP INC | 08/13/2024 | 3.71 M | $86.92 M | 0.96% | 6.25% |
| ALKEON CAPITAL MANAGEMENT LLC | 08/14/2024 | 3.33 M | $78.06 M | 0.00% | 5.61% |
| STATE STREET CORP | 08/14/2024 | 2.69 M | $63.09 M | -29.18% | 4.53% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 1.91 M | $44.76 M | 17.68% | 3.22% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 1.77 M | $41.46 M | 60.36% | 2.98% |
| BOXER CAPITAL, LLC | 08/14/2024 | 1.68 M | $39.34 M | 0.00% | 2.83% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.62 M | $37.99 M | 14.07% | 2.73% |
| REDMILE GROUP, LLC | 08/14/2024 | 1.61 M | $37.88 M | -13.14% | 2.72% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 1.50 M | $35.19 M | 8.10% | 2.53% |
| YIHENG CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 1.43 M | $33.65 M | 0.00% | 2.42% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 1.10 M | $25.74 M | -59.57% | 1.85% |
| BRAIDWELL LP | 08/14/2024 | 1.08 M | $25.44 M | 100.00% | 1.83% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 1.07 M | $25.20 M | -17.36% | 1.81% |
| MORGAN STANLEY | 10/17/2024 | 946,528 | $22.21 M | 134.37% | 1.60% |
| LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 800,000 | $18.77 M | 0.00% | 1.35% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 782,950 | $18.37 M | 32.74% | 1.32% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 08/14/2024 | 719,604 | $16.88 M | 118.99% | 1.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/14/2024 | 625,087 | $14.66 M | 56.29% | 1.05% |
| NORTHERN TRUST CORP | 08/14/2024 | 587,866 | $13.79 M | -1.64% | 0.99% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 554,865 | $13.02 M | 7.06% | 0.94% |
| JPMORGAN CHASE & CO | 08/12/2024 | 542,267 | $12.72 M | 66.65% | 0.91% |
| EMERALD ADVISERS, LLC | 08/06/2024 | 515,252 | $12.09 M | -4.38% | 0.87% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 441,794 | $10.36 M | -36.50% | 0.74% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 08/06/2024 | 424,901 | $9.97 M | 0.00% | 0.72% |
| UNIVERSITY OF WISCONSIN FOUNDATION | 08/14/2024 | 423,849 | $9.94 M | 13.76% | 0.71% |
| CITADEL ADVISORS LLC | 08/14/2024 | 395,117 | $9.27 M | -5.85% | 0.67% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 385,990 | $9.06 M | 15.94% | 0.65% |
| PROPEL BIO MANAGEMENT, LLC | 08/12/2024 | 327,752 | $7.69 M | 0.00% | 0.55% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 326,047 | $7.65 M | -0.22% | 0.55% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 315,717 | $7.41 M | -22.45% | 0.53% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2024 | 283,372 | $6.65 M | -16.66% | 0.48% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 262,230 | $6.15 M | -38.43% | 0.44% |
| JANE STREET GROUP, LLC | 08/15/2024 | 257,534 | $6.04 M | 2.98% | 0.43% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 251,234 | $5.89 M | 32.76% | 0.42% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 08/12/2024 | 246,463 | $5.78 M | 44.17% | 0.42% |
| SIMPLIFY ASSET MANAGEMENT INC. | 08/12/2024 | 245,487 | $5.76 M | -0.08% | 0.41% |
| ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 237,494 | $5.57 M | 2.13% | 0.40% |
| RHEOS CAPITAL WORKS INC. | 07/24/2024 | 216,000 | $5.07 M | 100.00% | 0.36% |
| WOODLINE PARTNERS LP | 08/14/2024 | 200,432 | $4.70 M | 56.05% | 0.34% |
| ABRDN PLC | 08/09/2024 | 199,237 | $4.67 M | 0.00% | 0.34% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 193,836 | $4.55 M | 100.00% | 0.33% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 174,903 | $4.10 M | 20.74% | 0.29% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 169,591 | $3.98 M | -78.60% | 0.29% |
| TD ASSET MANAGEMENT INC | 08/02/2024 | 154,592 | $3.63 M | 23.68% | 0.26% |
Akero Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of AKRO shares?
During the previous two years, 182 institutional investors and hedge funds held shares of Akero Therapeutics, Inc.. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 7.9 M
JANUS HENDERSON GROUP PLC: 7.08 M
RTW INVESTMENTS, LP: 5.92 M
BlackRock Funding, Inc. /DE: 5.75 M
GENERAL ATLANTIC, L.P.: 5.23 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.81 M
-
What percentage of Akero Therapeutics, Inc. stock is owned by institutional investors?
121.01% of Akero Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at AKRO ?
Institutional investors have bought a total of 79.96 M shares in the last 24 months. This purchase volume represents approximately $2.45 B in transactions.